Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Embecta Corp
EMBC | US
8.79
USD-0.02
-0.23%
EMBC | US
About Embecta Corp
Sector
Healthcare
Industry
Medical Instruments & Supplies
Earnings date
30/06/2024
As of date
13/03/2026
Close
8.79
Open
8.83
High
8.95
Low
8.78
Embecta Corp. a medical device company focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles syringes and safety devices as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany New Jersey.
View LessEMBC | US
Risk
28.2
Sharpe
-0.69
Luna's Score
45/100
Recommendation
Sell
Luna says (EMBC | US)
What's Working
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
23.9%1 month
28.2%3 months
40.1%6 months
41.3%Returns
Fundamental Ratios
PE
11.37
Fwd. PE
-
Price to book
2.61
Debt to equity
-2.16
Debt to assets
1.30
Ent. to EBITDA
10.35
Ent. to rev.
1.91
PEG
-
Other Fundamentals
EBITDA
230.40M
MarketCap
507.20M
MarketCap(USD)
507.20M
Div. yield
4.40
Op. margin
29.98
Erngs. growth
-3.80
Rev. growth
-4.80
Ret. on equity
-
Short ratio
3.30
Short perc.
3.90
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
1.57
Range1M
2.13
Range3M
4.67
Volumes: Market Activity
Rel. volume
0.81
Price X volume
6.37M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 10.35 | - | Expensive |
| Ent. to Revenue | 1.91 | - | Cheaper |
| PE Ratio | 11.37 | 47.18 | Cheaper |
| Price to Book | 2.61 | 5.71 | Cheaper |
| Dividend Yield | 4.40 | - | Leader |
| Std. Deviation (3M) | 40.06 | - | Lower Risk |
| Debt to Equity | -2.16 | 0.92 | Cheaper |
| Debt to Assets | 1.30 | 0.27 | Expensive |
| Market Cap | 507.20M | - | Emerging |
